ERASVSRXST• 12 Months (Normalized)
ERAS vs RXST (Erasca Inc. vs RxSight Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ERAS Performance $15.88
+886.34%
Erasca Inc.
Normalized Baseline0.00%
RXST Performance $6.02
-36.09%
RxSight Inc.
Normalized Baseline0.00%
Alpha Spread Margin ERAS LEADS
+922.43%
ERAS outperforming by 922.43%
ERASRXST
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ERAS RXST
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ERAS Price | ERAS Gain (%) | RXST Price | RXST Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $15.88 | +886.34% | $6.02 | -36.09% | +922.43% |
| Sep 10, 2026 | $16.03 | +895.65% | $5.96 | -36.73% | +932.38% |
| Sep 09, 2026 | $15.70 | +875.16% | $6.33 | -32.80% | +907.96% |
| Sep 08, 2026 | $16.28 | +911.18% | $6.45 | -31.53% | +942.71% |
| Sep 04, 2026 | $16.19 | +905.59% | $6.38 | -32.32% | +937.91% |
| Sep 03, 2026 | $16.26 | +909.94% | $6.54 | -30.57% | +940.51% |
| Sep 02, 2026 | $16.37 | +916.77% | $7.03 | -25.37% | +942.14% |
| Sep 01, 2026 | $16.76 | +940.99% | $6.99 | -25.80% | +966.79% |
| Aug 31, 2026 | $17.88 | +1010.56% | $7.33 | -22.19% | +1032.75% |
| Aug 28, 2026 | $18.03 | +1019.88% | $7.05 | -25.16% | +1045.04% |
| Aug 27, 2026 | $19.49 | +1110.56% | $6.61 | -29.83% | +1140.39% |
| Aug 26, 2026 | $19.15 | +1089.44% | $6.38 | -32.27% | +1121.71% |
| Aug 25, 2026 | $17.76 | +1003.11% | $6.40 | -32.06% | +1035.17% |
| Aug 24, 2026 | $17.60 | +993.17% | $6.26 | -33.55% | +1026.72% |
| Aug 21, 2026 | $17.63 | +995.03% | $6.25 | -33.65% | +1028.68% |
Page 1 of 17